NO981071L - Hydrolyse-fremmende taksan-hydrofobiske derivater - Google Patents

Hydrolyse-fremmende taksan-hydrofobiske derivater

Info

Publication number: NO981071L
Authority: NO; Norway
Prior art keywords: taxane; hydrolysis; promoting; hydrocarbon; hydrophobic derivatives
Prior art date: 1995-09-12

Application number

NO981071A

Other languages

English (en)

Other versions

NO981071D0 (no

NO319521B1 (no

Inventor

Eric Mayhew

Shaukat Ali

Andrew Stuart Janoff

Original Assignee

Liposome Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-12

Filing date

1998-03-11

Publication date

1998-05-12

1998-03-11 Application filed by Liposome Co Inc filed Critical Liposome Co Inc

1998-03-11 Publication of NO981071D0 publication Critical patent/NO981071D0/no

1998-05-12 Publication of NO981071L publication Critical patent/NO981071L/no

2005-08-22 Publication of NO319521B1 publication Critical patent/NO319521B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Medicinal Preparation (AREA)

NO19981071A 1995-09-12 1998-03-11 Hydrolysefremmende taksan-hydrofobiske derivater, sammensetninger og anvendelse derav. NO319521B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US357595P	1995-09-12	1995-09-12
PCT/US1996/014631 WO1997010234A1 (en)	1995-09-12	1996-09-12	Hydrolysis-promoting taxane hydrophobic derivatives

Publications (3)

Publication Number	Publication Date
NO981071D0 NO981071D0 (no)	1998-03-11
NO981071L true NO981071L (no)	1998-05-12
NO319521B1 NO319521B1 (no)	2005-08-22

Family

ID=21706522

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19981071A NO319521B1 (no)	1995-09-12	1998-03-11	Hydrolysefremmende taksan-hydrofobiske derivater, sammensetninger og anvendelse derav.

Country Status (21)

Country	Link
US (1)	US5703117A (no)
EP (1)	EP0902783B1 (no)
JP (1)	JP4192208B2 (no)
KR (1)	KR100401220B1 (no)
CN (1)	CN1100770C (no)
AT (2)	ATE309235T1 (no)
CA (1)	CA2231750C (no)
CZ (1)	CZ288562B6 (no)
DE (2)	DE69635428T2 (no)
DK (2)	DK1229030T3 (no)
ES (2)	ES2252347T3 (no)
HU (1)	HU226325B1 (no)
IL (1)	IL123595A (no)
MX (1)	MX9801871A (no)
NO (1)	NO319521B1 (no)
NZ (1)	NZ318300A (no)
PL (1)	PL187738B1 (no)
PT (1)	PT902783E (no)
SK (1)	SK283199B6 (no)
TR (1)	TR199800443T1 (no)
WO (1)	WO1997010234A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6107332A (en) *	1995-09-12	2000-08-22	The Liposome Company, Inc.	Hydrolysis-promoting hydrophobic taxane derivatives
US6667053B1 (en) *	1996-02-16	2003-12-23	Elan Pharmaceuticals, Inc.	D and L etherlipid stereoisomers and liposomes
US5912264A (en) *	1997-03-03	1999-06-15	Bristol-Myers Squibb Company	6-halo-or nitrate-substituted paclitaxels
US8853260B2 (en)	1997-06-27	2014-10-07	Abraxis Bioscience, Llc	Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
JP2001522799A (ja)	1997-11-10	2001-11-20	メモリアルスローン−ケタリングキャンサーセンター	三酸化ヒ素製剤の製造方法および三酸化ヒ素またはメラルソプロールを使用する癌の治療方法
BR9911031A (pt) *	1998-05-20	2002-01-29	Liposome Co Inc	Novas formulações em partìculas
US7314637B1 (en)	1999-06-29	2008-01-01	Neopharm, Inc.	Method of administering liposomal encapsulated taxane
US6146659A (en) *	1998-07-01	2000-11-14	Neopharm, Inc.	Method of administering liposomal encapsulated taxane
EP1143968B9 (en) *	1999-01-12	2004-08-04	Quanam Medical Corporation	Composition and methods for administration of water-insoluble paclitaxel derivatives
WO2001024763A2 (en)	1999-10-01	2001-04-12	Immunogen, Inc.	Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
EP1301500B1 (en)	2000-06-22	2007-11-21	Nitromed, Inc.	Nitrosated and nitrosylated taxanes, compositions and methods of use
US6607689B1 (en) *	2000-08-29	2003-08-19	Micron Technology, Inc.	Layer thickness control for stereolithography utilizing variable liquid elevation and laser focal length
EP1304103B1 (en) *	2001-10-22	2008-12-31	Viroblock SA	New non-phospholipid lipid vesicles (npLV) and their use in cosmetic, therapeutic and prophylactic applications
CA2466851C (en) *	2001-11-26	2012-09-11	Supergen, Inc.	Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
DE60335279D1 (de) *	2002-06-26	2011-01-20	Medigene Ag	Neues verfahren zur stabilisierung von diagnostischen und therapeutischen verbindungen in einem kationischen trägersystem
BRPI0407096A (pt)	2003-02-03	2006-01-24	Neopharm Inc	Taxano encapsulado em lipossomo estável, estéril e filtrável e outros fármacos antineoplásicos
EP3345632A1 (en) *	2005-02-18	2018-07-11	Abraxis BioScience, LLC	Drugs with improved hydrophobicity for incorporation in medical devices
JP2008535927A (ja) *	2005-04-12	2008-09-04	ウィスコンシンアルムニリサーチファンデイション	ポリマー及びパッセンジャー薬のミセル組成物
WO2009126401A1 (en) *	2008-04-10	2009-10-15	Abraxis Bioscience, Llc	Compositions of hydrophobic taxane derivatives and uses thereof
RU2010145529A (ru) *	2008-04-10	2012-05-20	АБРАКСИС БАЙОСАЙЕНС ЭлЭлСи (US)	Композиции гидрофобных производных таксана и их применение
US8236329B2 (en)	2009-09-25	2012-08-07	Wisconsin Alumni Research Foundation	Micelle encapsulation of therapeutic agents
CN105503844A (zh) *	2015-12-11	2016-04-20	上海大学	C-13和c-7位结构改造的紫杉醇类化合物及其制备方法
CN111004195B (zh) *	2019-12-03	2022-01-28	沈阳药科大学	卡巴他赛弱碱性衍生物及其制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5059699A (en) *	1990-08-28	1991-10-22	Virginia Tech Intellectual Properties, Inc.	Water soluble derivatives of taxol
US5278324A (en) *	1990-08-28	1994-01-11	Virginia Tech Intellectual Properties, Inc.	Water soluble derivatives of taxol
JP3492690B2 (ja) *	1992-12-23	2004-02-03	ブリストル‐マイアーズスクイブカンパニー	新規な側鎖をもつタキサン類およびその中間体類
IL108316A (en) *	1993-01-15	2006-10-31	Univ Florida State	C10 taxane derivatives and pharmaceutical compositions containing them
US5580899A (en) *	1995-01-09	1996-12-03	The Liposome Company, Inc.	Hydrophobic taxane derivatives

1996
- 1996-09-12 EP EP96930847A patent/EP0902783B1/en not_active Expired - Lifetime
- 1996-09-12 WO PCT/US1996/014631 patent/WO1997010234A1/en not_active Ceased
- 1996-09-12 DK DK02008590T patent/DK1229030T3/da active
- 1996-09-12 DK DK96930847T patent/DK0902783T3/da active
- 1996-09-12 US US08/712,684 patent/US5703117A/en not_active Expired - Fee Related
- 1996-09-12 CA CA002231750A patent/CA2231750C/en not_active Expired - Fee Related
- 1996-09-12 IL IL12359596A patent/IL123595A/xx not_active IP Right Cessation
- 1996-09-12 CN CN96198237A patent/CN1100770C/zh not_active Expired - Fee Related
- 1996-09-12 DE DE69635428T patent/DE69635428T2/de not_active Expired - Fee Related
- 1996-09-12 ES ES02008590T patent/ES2252347T3/es not_active Expired - Lifetime
- 1996-09-12 AT AT02008590T patent/ATE309235T1/de not_active IP Right Cessation
- 1996-09-12 CZ CZ1998711A patent/CZ288562B6/cs not_active IP Right Cessation
- 1996-09-12 HU HU9901433A patent/HU226325B1/hu unknown
- 1996-09-12 PL PL96325477A patent/PL187738B1/pl not_active IP Right Cessation
- 1996-09-12 TR TR1998/00443T patent/TR199800443T1/xx unknown
- 1996-09-12 MX MX9801871A patent/MX9801871A/es not_active IP Right Cessation
- 1996-09-12 NZ NZ318300A patent/NZ318300A/xx unknown
- 1996-09-12 KR KR10-1998-0701653A patent/KR100401220B1/ko not_active Expired - Fee Related
- 1996-09-12 ES ES96930847T patent/ES2179208T3/es not_active Expired - Lifetime
- 1996-09-12 JP JP51210297A patent/JP4192208B2/ja not_active Expired - Fee Related
- 1996-09-12 PT PT96930847T patent/PT902783E/pt unknown
- 1996-09-12 SK SK334-98A patent/SK283199B6/sk unknown
- 1996-09-12 AT AT96930847T patent/ATE216377T1/de not_active IP Right Cessation
- 1996-09-12 DE DE69620802T patent/DE69620802T2/de not_active Expired - Fee Related
1998
- 1998-03-11 NO NO19981071A patent/NO319521B1/no unknown

Also Published As

Publication number	Publication date
EP0902783B1 (en)	2002-04-17
AU706290B2 (en)	1999-06-10
SK283199B6 (sk)	2003-03-04
NO981071D0 (no)	1998-03-11
EP0902783A4 (no)	1999-03-24
US5703117A (en)	1997-12-30
WO1997010234A1 (en)	1997-03-20
KR19990044409A (ko)	1999-06-25
HU226325B1 (en)	2008-08-28
HUP9901433A2 (hu)	2001-04-28
DK1229030T3 (da)	2006-02-13
PL325477A1 (en)	1998-07-20
IL123595A0 (en)	1998-10-30
DE69635428D1 (de)	2005-12-15
JP2001519755A (ja)	2001-10-23
ATE216377T1 (de)	2002-05-15
HUP9901433A3 (en)	2001-05-28
TR199800443T1 (xx)	1998-06-22
CA2231750A1 (en)	1997-03-20
PT902783E (pt)	2002-09-30
EP0902783A1 (en)	1999-03-24
HK1016169A1 (en)	1999-10-29
DK0902783T3 (da)	2002-07-22
AU6975696A (en)	1997-04-01
CA2231750C (en)	2006-07-11
NZ318300A (en)	1999-08-30
PL187738B1 (pl)	2004-09-30
ES2252347T3 (es)	2006-05-16
CN1202166A (zh)	1998-12-16
CN1100770C (zh)	2003-02-05
NO319521B1 (no)	2005-08-22
DE69620802D1 (de)	2002-05-23
JP4192208B2 (ja)	2008-12-10
CZ288562B6 (cs)	2001-07-11
KR100401220B1 (ko)	2004-03-20
DE69635428T2 (de)	2006-06-14
ES2179208T3 (es)	2003-01-16
SK33498A3 (en)	1998-08-05
IL123595A (en)	2000-10-31
CZ71198A3 (cs)	1998-07-15
DE69620802T2 (de)	2002-10-10
MX9801871A (es)	1998-05-31
ATE309235T1 (de)	2005-11-15

Publication	Publication Date	Title
DK1229030T3 (da)	2006-02-13	Hydrolysefremmende, hydrofobe taxanderivater
DE69713526D1 (de)	2002-07-25	Lösliche prodrugs von paclitaxel
MX9603479A (es)	1997-12-31	Derivados de 4-amino de acido micofenolico con actividad inmunosupresora.
EA200000282A1 (ru)	2000-10-30	Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
PT1063234E (pt)	2003-09-30	Derivados de taxano hidrofobos
FI952248A7 (fi)	1995-05-09	Kasvainvastaisia koostumuksia, jotka sisältävät taksaanijohdannaisia
TR200102603T2 (tr)	2002-01-21	Antitümör aktiviteye sahip olan kamptotesin türevleri
PT977564E (pt)	2005-08-31	Forscolina para promocao da massa corporal magra
NL970006I2 (nl)	1997-10-01	Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
DE59611341D1 (de)	2006-06-01	Verwendung von saccharid-konjugaten
CY1109695T1 (el)	2014-08-13	Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο
DE69631975D1 (de)	2004-04-29	Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
SE8404283D0 (sv)	1984-08-28	Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
ATE141796T1 (de)	1996-09-15	2',5'-oligoadenylat-derivate zur verwendung als heilmittel
ES2169124T3 (es)	2002-07-01	Acido 4-aminomicofenolico 6-sustituido y derivados con actividad inmunosupresora.
EP1229030A3 (en)	2002-09-25	Hydrolysis-promoting taxane hydrophobic derivates
RU94018405A (ru)	1996-04-27	Устройство для воздействия магнитным полем
IT208536Z2 (it)	1988-05-28	Struttura di cannula vaginale monouso, per l'applicazione di pomate, medicamenti semidensi e simili.